Sepsis Research Using Omics Technology in the European Union and the United Kingdom: Maps, Trends, and Future Implications.

IF 2.2 3区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Jestina Rachel Kurian, Nikolaos Evangelatos, Asha Kamath, Helmut Brand
{"title":"Sepsis Research Using Omics Technology in the European Union and the United Kingdom: Maps, Trends, and Future Implications.","authors":"Jestina Rachel Kurian, Nikolaos Evangelatos, Asha Kamath, Helmut Brand","doi":"10.1089/omi.2024.0089","DOIUrl":null,"url":null,"abstract":"<p><p>High-throughput omics technologies have become valuable tools for systems science research and clinical management of sepsis. This article analyzes sepsis research using omics technologies in the European Union (EU) and the United Kingdom from 1990 to May 2023 using bibliometric data from the Web of Science database. Using VOSviewer for network analysis, we examined the distribution patterns, funding characteristics, and collaborations among the states, noting trends of convergence and divergence. The analysis included 2078 articles, revealing an increasing rate of publications on sepsis research using omics approaches. The United Kingdom's research output is notably high, contributing 28.3% of the total research from the EU and United Kingdom combined. Germany, France, the Netherlands, and Italy together account for 56.9% of the publications from the EU member states. The United States is the leading international collaborator, particularly with the United Kingdom, followed by Germany and France. The EU-15 countries have significantly more publication outputs in this domain with growing but limited inclusion of the newer members of the EU. We suggest that the role of EU member states and the United Kingdom in sepsis research using omics technologies can be advanced by facilitating high-value, technology-driven health research, fostering collaboration, convergence, and equity in global health and biomedical research.</p>","PeriodicalId":19530,"journal":{"name":"Omics A Journal of Integrative Biology","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Omics A Journal of Integrative Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/omi.2024.0089","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

High-throughput omics technologies have become valuable tools for systems science research and clinical management of sepsis. This article analyzes sepsis research using omics technologies in the European Union (EU) and the United Kingdom from 1990 to May 2023 using bibliometric data from the Web of Science database. Using VOSviewer for network analysis, we examined the distribution patterns, funding characteristics, and collaborations among the states, noting trends of convergence and divergence. The analysis included 2078 articles, revealing an increasing rate of publications on sepsis research using omics approaches. The United Kingdom's research output is notably high, contributing 28.3% of the total research from the EU and United Kingdom combined. Germany, France, the Netherlands, and Italy together account for 56.9% of the publications from the EU member states. The United States is the leading international collaborator, particularly with the United Kingdom, followed by Germany and France. The EU-15 countries have significantly more publication outputs in this domain with growing but limited inclusion of the newer members of the EU. We suggest that the role of EU member states and the United Kingdom in sepsis research using omics technologies can be advanced by facilitating high-value, technology-driven health research, fostering collaboration, convergence, and equity in global health and biomedical research.

欧盟和英国利用 Omics 技术开展败血症研究:地图、趋势和未来影响》。
高通量 omics 技术已成为系统科学研究和败血症临床管理的重要工具。本文利用科学网数据库(Web of Science)的文献计量数据,分析了欧盟(EU)和英国从 1990 年到 2023 年 5 月期间利用组学技术开展的败血症研究。我们使用 VOSviewer 进行网络分析,研究了各国之间的分布模式、资金特点和合作情况,并注意到了趋同和分歧的趋势。该分析包括 2078 篇文章,揭示了使用全息方法进行败血症研究的论文发表率越来越高。英国的研究成果明显较高,占欧盟和英国总研究成果的 28.3%。德国、法国、荷兰和意大利发表的论文共占欧盟成员国发表论文总数的 56.9%。美国是主要的国际合作者,尤其是与英国的合作,其次是德国和法国。欧盟 15 国在这一领域的出版物数量明显较多,欧盟新成员国的出版物数量不断增加,但数量有限。我们建议,欧盟成员国和英国可以通过促进高价值、技术驱动型健康研究,促进全球健康和生物医学研究领域的合作、趋同和公平,在利用 omics 技术开展败血症研究方面发挥更大的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Omics A Journal of Integrative Biology
Omics A Journal of Integrative Biology 生物-生物工程与应用微生物
CiteScore
6.00
自引率
12.10%
发文量
62
审稿时长
3 months
期刊介绍: OMICS: A Journal of Integrative Biology is the only peer-reviewed journal covering all trans-disciplinary OMICs-related areas, including data standards and sharing; applications for personalized medicine and public health practice; and social, legal, and ethics analysis. The Journal integrates global high-throughput and systems approaches to 21st century science from “cell to society” – seen from a post-genomics perspective.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信